A regulatory cross-talk between Vγ9Vδ2 T lymphocytes and mesenchymal stem cells

European Journal of Immunology

Volumn 39, Issue 3, 2009, Pages 752-762

  Martinet, Ludovic ^a,b   Fleury Cappellesso, Sandrine ^c   Gadelorge, Mélanie ^c   Dietrich, Gilles ^a,b   Bourin, Philippe ^c   Fournie, Jean Jacques ^a,b   Poupot, Remy ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

T cells; Immune regulation; Mesenchymal stem cells; Prostaglandin E2

Indexed keywords

CYCLOOXYGENASE 2; GAMMA INTERFERON; PROSTAGLANDIN E2; LYMPHOCYTE ANTIGEN RECEPTOR; PROSTAGLANDIN E RECEPTOR; PTGS2 PROTEIN, HUMAN; T CELL RECEPTOR VDELTA2, HUMAN; T CELL RECEPTOR VGAMMA9, HUMAN; T-CELL RECEPTOR VDELTA2, HUMAN; T-CELL RECEPTOR VGAMMA9, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; B CELL LYMPHOMA; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY; GENE ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; MESENCHYMAL STEM CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TARGET CELL DESTRUCTION; TUMOR IMMUNITY; BIOSYNTHESIS; CELL COMMUNICATION; DRUG ANTAGONISM; IMMUNOLOGY; METABOLISM; SIGNAL TRANSDUCTION;

CELL COMMUNICATION; CYCLOOXYGENASE 2; DINOPROSTONE; HUMANS; INTERFERON-GAMMA; MESENCHYMAL STEM CELLS; RECEPTOR CROSS-TALK; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, PROSTAGLANDIN E; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 64049097932     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200838812     Document Type: Article

References (56)

1. Poupot, M. and Fournie, J. J., Non-peptide antigens activating human Vgamma9/Vdelta2 T lymphocytes. Immunol. Lett. 2004. 95: 129-138.
2. Bonneville, M. and Scotet, E., Human Vgamma9Vdelta2 T-cells: promising new leads for immunotherapy of infections and tumors. Curr. Opin. Immunol. 2006. 18: 539-546.
3. Ismaili, J., Olislagers, V., Poupot, R., Fournie, J. J. and Goldman, M., Human gamma delta T-cells induce dendritic cell maturation. Clin. Immunol. 2002. 103: 296-302.
4. Dieli, F., Caccamo, N., Meraviglia, S., Ivanyi, J., Sireci, G., Bonanno, C. T., Ferlazzo, V. et al., Reciprocal stimulation of gammadelta T-cells and dendritic cells during the anti-mycobacterial immune response. Eur. J. Immunol. 2004. 34: 3227-3235.
5. Devilder, M. C., Maillet, S., Bouyge-Moreau, I., Donnadieu, E., Bonneville, M. and Scotet, E., Potentiation of antigen-stimulated V gamma 9V delta 2 T-cell cytokine production by immature dendritic cells (DC) and reciprocal effect on DC maturation. J. Immunol. 2006. 176: 1386-1393.
6. Dieli, F., Poccia, F., Lipp, M., Sireci, G., Caccamo, N., Di Sano, C. and Salerno, A., Differentiation of effector/memory Vdelta2 T-cells and migratory routes in lymph nodes or inflammatory sites. J. Exp. Med. 2003. 198: 391-397.
7. Angelini, D. F., Borsellino, G., Poupot, M., Diamantini, A., Poupot, R., Bernardi, G., Poccia, F. et al., FcgammaRIII discriminates between 2 subsets of Vgamma9Vdelta2 effector cells with different responses and activation pathways. Blood 2004. 104: 1801-1807.
8. Caccamo, N., Battistini, L., Bonneville, M., Poccia, F., Fournie, J. J., Meraviglia, S., Borsellino, G. et al., CXCR5 identifies a subset of Vgamma9Vdelta2 T-cells which secrete IL-4 and IL-10 and help B cells for antibody production. J. Immunol. 2006. 177: 5290-5295.
9. + T-cells during mycobacterial infections. Science 2002. 295: 2255-2258.
10. Worku, S., Gorse, G. J., Belshe, R. B. and Hoft, D. F., Canarypox vaccines induce antigen-specific human gammadelta T-cells capable of interferon-gamma production. J. Infect. Dis. 2001. 184: 525-532.
11. Agrati, C., Castilletti, C., De Santis, R., Cimini, E., Bordi, L., Malkovsky, M., Poccia, F. and Capobianchi, M. R., Interferon-gamma-mediated antiviral immunity against orthopoxvirus infection is provided by gamma delta T-cells. J. Infect. Dis. 2006. 193: 1606-1607; author reply 1607-1608.
12. Espinosa, E., Belmant, C., Pont, F., Luciani, B., Poupot, R., Romagne, F., Brailly, H. et al., Chemical synthesis and biological activity of bromohydrin pyrophosphate, a potent stimulator of human gamma delta T-cells. J. Biol. Chem. 2001. 276: 18337-18344.
13. Cendron, D., Ingoure, S., Martino, A., Casetti, R., Horand, F., Romagne, F., Sicard, H. et al., A tuberculosis vaccine based on phosphoantigens and fusion proteins induces distinct gammadelta and alphabeta T-cell responses in primates. Eur. J. Immunol. 2007. 37: 549-565.
14. Sicard, H., Ingoure, S., Luciani, B., Serraz, C., Fournie, J. J., Bonneville, M., Tiollier, J. and Romagne, F., In vivo immunomanipulation of V gamma 9V delta 2 T-cells with a synthetic phosphoantigen in a preclinical nonhuman primate model. J. Immunol. 2005. 175: 5471-5480.
15. Kobayashi, H., Tanaka, Y., Yagi, J., Toma, H. and Uchiyama, T., Gamma/delta T-cells provide innate immunity against renal cell carcinoma. Cancer Immunol. Immunother. 2001. 50: 115-124.
16. Kunzmann, V. and Wilhelm, M., Anti-lymphoma effect of gammadelta T-cells. Leuk. Lymphoma 2005. 46: 671-680.
17. Lamb, L. S., Jr. and Lopez, R. D., Gammadelta T-cells: A new frontier for immunotherapy? Biol. Blood Marrow Transplant. 2005. 11: 161-168.
18. Viey, E., Fromont, G., Escudier, B., Morel, Y., Da Rocha, S., Chouaib, S. and Caignard, A., Phosphostim-activated gamma delta T-cells kill autologous metastatic renal cell carcinoma. J. Immunol. 2005. 174: 1338-1347.
19. Rabinovich, G. A., Gabrilovich, D. and Sotomayor, E. M., Immunosuppressive strategies that are mediated by tumor cells. Annu. Rev. Immunol. 2007. 25: 267-296.
20. Hall, B. Andreeff, M. and Marini, F., The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles. Handb. Exp. Pharmacol. 2007. 180: 263-283.
21. Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L. et al., Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007. 449: 557-563.
22. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A. et al., Multilineage potential of adult human mesenchymal stem cells. Science 1999. 284: 143-147.
23. Barry, F. P., Biology and clinical applications of mesenchymal stem cells. Birth Defects Res. C Embryo Today 2003. 69: 250-256.
24. Jorgensen, C., Djouad, F., Apparailly, F. and Noel, D., Engineering mesenchymal stem cells for immunotherapy. Gene Ther. 2003. 10: 928-931.
25. Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., Grisanti, S. and Gianni, A.M., Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002. 99: 3838-3843.
26. Glennie, S., Soeiro, I., Dyson, P. J., Lam, E. W. and Dazzi, F., Bone marrow mesenchymal stem cells induce division arrest anergy of activated T-cells. Blood 2005. 105: 2821-2827.
27. Krampera, M., Glennie, S., Dyson, J., Scott, D., Laylor, R., Simpson, E. and Dazzi, F., Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T-cells to their cognate peptide. Blood 2003. 101: 3722-3729.
28. Sotiropoulou, P. A., Perez, S. A., Gritzapis, A. D., Baxevanis, C. N., Papamichail, M., Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 2006. 24: 74-85.
29. Spaggiari, G. M., Capobianco, A., Becchetti, S., Mingari, M. C. and Moretta, L., Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 2006. 107: 1484-1490.
30. Aggarwal, S. and Pittenger, M. F., Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005. 105: 1815-1822.
31. +-derived and monocyte-derived dendritic cells. J. Immunol. 2006. 177: 2080-2087.
32. Uccelli, A., Moretta, L. and Pistoia, V., Immunoregulatory function of mesenchymal stem cells. Eur. J. Immunol. 2006. 36: 2566-2573.
33. Djouad, F., Plence, P., Bony, C., Tropel, P., Apparailly, F., Sany, J., Noel, D. and Jorgensen, C., Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003. 102: 3837-3844.
34. Chen, L., Cencioni, M. T., Angelini, D. F., Borsellino, G., Battistini, L. and Brosnan, C. F., Transcriptional profiling of gamma delta T-cells identifies a role for vitamin D in the immunoregulation of the V gamma 9V delta 2 response to phosphate-containing ligands. J. Immunol. 2005. 174: 6144-6152.
35. Rojas, R. E., Balaji, K. N., Subramanian, A. and Boom, W. H., Regulation of human CD4(+) alphabeta T-cell-receptor-positive (TCR(+)) and gamma-delta TCR(+) T-cell responses to Mycobacterium tuberculosis by interleukin-10 and transforming growth factor beta. Infect. Immun. 1999. 67: 6461-6472.
36. Gober, H. J., Kistowska, M., Angman, L., Jeno, P., Mori, L. and De Libero, G., Human T-cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells. J. Exp. Med. 2003. 197: 163-168.
37. Bygdeman, M., Pharmacokinetics of prostaglandins. Best Pract. Res. Clin. Obstet. Gynaecol. 2003. 17: 707-716.
38. Sugimoto, Y. and Narumiya, S., Prostaglandin E receptors. J. Biol. Chem. 2007. 282: 11613-11617.
39. Blanco, J. C., Contursi, C., Salkowski, C. A., DeWitt, D. L., Ozato, K. and Vogel, S. N., Interferon regulatory factor (IRF)-1 and IRF-2 regulate interferon gamma-dependent cyclooxygenase 2 expression. J. Exp. Med. 2000. 191: 2131-2144.
40. Chen, C. C., Sun, Y. T., Chen, J. J. and Chiu, K. T., TNF-alpha-induced cyclooxygenase-2 expression in human lung epithelial cells: Involvement of the phospholipase C-gamma 2, protein kinase C-alpha, tyrosine kinase, NF-kappa B-inducing kinase, and I-kappa B kinase 1/2 pathway. J. Immunol. 2000. 165: 2719-2728.
41. Harris, S. G., Padilla, J., Koumas, L., Ray, D. and Phipps, R. P., Prostaglandins as modulators of immunity. Trends Immunol. 2002. 23: 144-150.
42. DeLong, P., Tanaka, T., Kruklitis, R., Henry, A. C., Kapoor, V., Kaiser, L. R., Sterman, D. H. and Albelda, S. M., Use of cyclooxygenase-2 inhibition to enhance the efficacy of immunotherapy. Cancer Res. 2003. 63: 7845-7852.
43. Blay, J., White, T. D. and Hoskin, D. W., The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine. Cancer Res. 1997. 57: 2602-2605.
44. Ren, G., Zhang, L., Zhao, X., Xu, G., Zhang, Y., Roberts, A. I., Zhao, R. C. and Shi, Y., Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2008. 2: 141-150.
45. Le Blanc, K. and Ringden, O., Mesenchymal stem cells: Properties and role in clinical bone marrow transplantation. Curr. Opin. Immunol. 2006. 18: 586-591.
46. Djouad, F., Fritz, V., Apparailly, F., Louis-Plence, P., Bony, C., Sany, J., Jorgensen, C. and Noel, D., Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum. 2005. 52: 1595-1603.
47. Zappia, E., Casazza, S., Pedemonte, E., Benvenuto, F., Bonanni, I., Gerdoni, E., Giunti, D. et al., Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 2005. 106: 1755-1761.
48. Rajan, A. J., Gao, Y. L., Raine, C. S. and Brosnan, C. F., A pathogenic role for gamma delta T-cells in relapsing-remitting experimental allergic encephalomyelitis in the SJL mouse. J. Immunol. 1996. 157: 941-949.
49. Spahn, T. W., Issazadah, S., Salvin, A. J. and Weiner, H. L., Decreased severity of myelin oligodendrocyte glycoprotein peptide 33 - 35-induced experimental autoimmune encephalomyelitis in mice with a disrupted TCR delta chain gene. Eur. J. Immunol. 1999. 29: 4060-4071.
50. Battistini, L., Selmaj, K., Kowal, C., Ohmen, J., Modlin, R. L., Raine, C. S. and Brosnan, C. F., Multiple sclerosis: Limited diversity of the V delta 2-J delta 3 T-cell receptor in chronic active lesions. Ann. Neurol. 1995. 37: 198-203.
51. Shimonkevitz, R., Colburn, C., Burnham, J. A., Murray, R. S. and Kotzin, B. L., Clonal expansions of activated gamma/delta T-cells in recent-onset multiple sclerosis. Proc. Natl. Acad. Sci. USA 1993. 90: 923-927.
52. Stinissen, P., Vandevyver, C., Medaer, R., Vandegaer, L., Nies, J., Tuyls, L., Hafler, D. A. et al., Increased frequency of gamma delta T-cells in cerebrospinal fluid and peripheral blood of patients with multiple sclerosis. Reactivity, cytotoxicity, and T-cell receptor V gene rearrangements. J. Immunol. 1995. 154: 4883-4894.
53. Dazzi, F., Ramasamy, R., Glennie, S., Jones, S. P. and Roberts, I., The role of mesenchymal stem cells in haemopoiesis. Blood Rev. 2006. 20: 161-171.
54. Krampera, M., Cosmi, L., Angeli, R., Pasini, A., Liotta, F., Andreini, A., Santarlasci, V. et al., Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 2006. 24: 386-398.
55. Fisch, P., Handgretinger, R. and Schaefer, H. E., Pure red cell aplasia. Br. J. Haematol. 2000. 111: 1010-1022.
56. Espinosa, E., Tabiasco, J., Hudrisier, D. and Fournie, J. J., Synaptic transfer by human gamma delta T-cells stimulated with soluble or cellular antigens. J. Immunol. 2002. 168: 6336-6343.